SCHEMBL8484373

SCHEMBL8484373

CCOC(=O)CCC(C#N)(CCCOC1CCCCO1)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SLC6A3 Q01959 5/20 0.35
OPRK1 P41145 2/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GAA P10253 2/20 0.33
MAPT P10636 1/20 0.33
OPRM1 P35372 1/20 0.33
TSHR P16473 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
CREBBP Q92793 1/20 0.31
EPHA2 P29317 1/20 0.31
P2RX3 P56373 2/20 0.31
KDM4C Q9H3R0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6543753 0.97 MEN1 (0.38) MEN1KMT2ASLC6A3OPRK1KDM4E
SCHEMBL6952332 0.95 SLC6A3 (0.36) MEN1KMT2ASLC6A3OPRK1KDM4E
SCHEMBL8485274 0.93 MEN1 (0.36) MEN1KMT2ASLC6A3OPRK1KDM4E
SCHEMBL7956480 0.92 MEN1 (0.39) MEN1KMT2ASLC6A3OPRK1KDM4E
SCHEMBL7426709 0.89 MEN1 (0.43) MEN1KMT2ASLC6A3EPHA2KDM4C
SCHEMBL3466801 0.87 MEN1 (0.34) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL6947257 0.87 SLC6A3 (0.37) MEN1KMT2ASLC6A3OPRK1KDM4E
SCHEMBL8124689 0.87 MEN1 (0.43) MEN1KMT2ASLC6A3ALDH1A1EPHA2
SCHEMBL7085251 0.86 SMN1; SMN2 (0.35) SLC6A3OPRK1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4678659 0.85 MEN1 (0.40) MEN1KMT2ASLC6A3OPRK1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5859029-A TREATING SUBSTANCE P-DEPENDENT PATHOLOGICAL CONDITIONS SANOFI (FR) 1999-01-12 US disclosed
US-5656639-A POSSESS STRONG AFFINITY FOR NK1 RECEPTORS; USEFUL IN TREATMENT OF SUBSTANCE P-DEPENDENT PATHOLOGICAL CONDITIONS SANOFI (FR) 1997-08-12 US disclosed